InsidersTradesSigma
Follow the 레이 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 레이 has recorded 141 public disclosures. Market capitalisation: €83.8bn. The latest transaction was filed on 13 July 2026 (Purchase). Among the most active insiders: 미래에셋자산운용. The full history is free.
137
Insider Decl.
n/a
Thresholds
€3m
40 ops.
Buy Volume
€117,409
72 ops.
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,633 of 29,062 companies
53.6
score / 100
Value68
Quality40
FCF yld11%
Earn yld3.7%
EV/EBITDA9.6x
ROE1.3%
Gross mgn47%
Net mgn2.8%
Debt/EBITDA4.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations141 total
Other
Other
Other
Other
25 of 141 declarations
Acerca de 레이
레이 es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se enfoca en el desarrollo y comercialización de productos farmacéuticos innovadores.